Kalpesh B Bhavsar, MD
Psychiatry · Rosemead
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 34 years
- Graduated 1992
Offices
3 locations · Kalpesh Bhavsar MD Professional Corporation · New U Therapy Center and Family Services Inc · Pacific Heritage Medical Group Inc
Looking this up.
Hospitals listed: Antelope Valley Hospital · Pomona Valley Hospital Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bhavsar’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A111070 · Current
Licensed to practise in California · since 2010 · expires 2028-02-29 · South Gujarat University, Government Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Antelope Valley HospitalLancaster, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Antelope Valley Medical CenterPatients rate it 1 of 5 · 44% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.414, Oct 2024 – Sep 2025
- Pomona Valley Hospital Medical CenterPomona, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Pomona Valley Hospital Medical CenterPatients rate it 2 of 5 · 68% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.64 (0.33 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.398, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.389, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.155, Oct 2024 – Sep 2025
See every measure and the patient survey for Antelope Valley Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 1 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.414 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.95) · 893 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.71 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.32 (140.53 to 244.12) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 11.4 · 58 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14.5 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 21.7 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15.1 · 434 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.9 · 2,893 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 4,216 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,261 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.11 (1.84 to 6.38) · 822 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.63 to 3.78) · 833 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.21 (4.53 to 21.89) · 224 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.37 (2.27 to 10.48) · 209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 169 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.4 (0 to 1.12) · 3,568 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 48 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.816 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.869 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.518 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.2 · 226 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 360 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 40.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 13.4 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 78.5 · 303 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 602 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.5 · 50 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.6 · 39 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 210 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.7) · 72 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 145 cases | No different | Jan 2024 – Dec 2024 |
What patients said (338 patients answered, 10% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 1 |
| Quietness | 1 |
| Recommend hospital | 1 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 67% |
| Doctors "always" communicated well | 65% |
| Staff "always" explained | 47% |
| Yes, staff "did" give patients this information | 79% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 59% |
| Doctors "always" listened carefully | 64% |
| Doctors "always" treated them with courtesy and respect | 74% |
| Patients who gave a rating of "9" or "10" (high) | 49% |
| Staff "always" explained new medications | 65% |
| Nurses "always" explained things so they could understand | 63% |
| Nurses "always" listened carefully | 64% |
| Nurses "always" treated them with courtesy and respect | 75% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 44% |
| Staff "always" explained possible side effects | 29% |
| Yes, staff "did" give patients information about possible symptoms | 81% |
See every measure and the patient survey for Pomona Valley Hospital Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.64 (0.33 to 0.96) | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.398 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.389 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.155 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.84) · 1,069 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 169.52 (120.62 to 218.41) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.7 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.2 · 369 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.5 · 190 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.7 · 583 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 5,235 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.42) · 5,161 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.2 (1.1 to 5.3) · 996 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.55 (0 to 3.22) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.88 (0.32 to 3.44) · 911 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.99 (0 to 12.42) · 189 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.25 (0.34 to 8.16) · 172 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 196 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.1 (0 to 0.65) · 4,157 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 64 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.953 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.438 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 278 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 982 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.1 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -51.4 · 454 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -29.1 · 219 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 453 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 7.6) · 74 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.3 (9.5 to 18.1) · 74 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 57 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.9 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 137 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.1 to 18) · 319 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 199 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,021 patients answered, 13% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$173,982
Medicare paid this office $173,982 for 341 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 167 | $110,786 | $56 |
| Short return visit (20+ min) | 86 | $29,982 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 140 | $14,253 | $91 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 88 | $5,358 | $11 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $4,231 | $58 |
See all 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 167 | $110,786 | $56 |
| Short return visit (20+ min) | 86 | $29,982 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 140 | $14,253 | $91 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 88 | $5,358 | $11 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $4,231 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,141 | $134 |
| New patient visit (30+ min) | 26 | $1,919 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,809 | $90 |
Who their Medicare patients are
341 Original Medicare patients in 2024. Average age 60 · Under 65 55% · 85 and older 4% · Women 52% · Also on Medicaid 77% · Health risk score 1.75. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 75% · Depression 75% · Diabetes 49% · COPD 29% · Chronic kidney disease 24% · Coronary heart disease 23% · Dementia 22% · Heart failure 21% · Stroke 16% · Atrial fibrillation 11% · Cancer 8%.
The office billed $475,067, Medicare allowed $241,753 and paid $173,982; for 3,281 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 341 | 3,281 | 60 | 1.75 | $475,067 | $173,982 |
| 2023 | 265 | 2,124 | 63 | 1.70 | $311,685 | $146,006 |
| 2022 | 314 | 2,191 | 62 | 1.87 | $299,623 | $138,240 |
| 2021 | 296 | 1,980 | 60 | 2.11 | $276,096 | $131,910 |
| 2020 | 335 | 2,396 | 59 | 1.97 | $334,742 | $159,217 |
| 2019 | 511 | 3,364 | 60 | 2.06 | $828,528 | $220,672 |
| 2018 | 496 | 3,129 | 60 | 2.10 | $879,725 | $216,542 |
| 2017 | 418 | 2,176 | 58 | 2.24 | $504,240 | $146,482 |
| 2016 | 291 | 1,386 | 60 | 2.51 | $318,400 | $99,369 |
| 2015 | 302 | 1,340 | 57 | 2.43 | $357,605 | $113,643 |
| 2014 | 329 | 1,593 | 58 | 2.21 | $412,995 | $130,255 |
| 2013 | 388 | 1,939 | 60 | 2.42 | $503,950 | $153,315 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 111 | $95,438 | $65 |
| Short return visit (20+ min) | 86 | $30,308 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 106 | $12,014 | $104 |
| New patient visit (30+ min) | 25 | $2,256 | $90 |
2022: 9 services
| Follow-up observation care per day, typically 25 minutes | 90 | $76,303 | $56 |
| Short return visit (20+ min) | 93 | $32,879 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 60 | $7,514 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $5,825 | $59 |
| Initial hospital observation care per day, typically 50 minutes | 39 | $4,392 | $100 |
| New patient visit (30+ min) | 37 | $2,959 | $80 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 23 | $1,875 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,627 | $86 |
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 13 | $1,271 | $91 |
2021: 9 services
| Follow-up observation care per day, typically 25 minutes | 83 | $73,189 | $60 |
| Short return visit (20+ min) | 64 | $20,987 | $72 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 61 | $7,337 | $111 |
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 26 | $6,659 | $89 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 45 | $6,596 | $58 |
| Initial hospital observation care per day, typically 50 minutes | 35 | $4,729 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,335 | $61 |
| New patient visit (30+ min) | 29 | $2,605 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,237 | $88 |
2020: 13 services
| Follow-up observation care per day, typically 25 minutes | 120 | $68,130 | $58 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 62 | $15,992 | $74 |
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 33 | $15,243 | $113 |
| Short return visit (20+ min) | 55 | $11,381 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 65 | $7,525 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $6,972 | $60 |
| Follow-up observation care per day, typically 15 minutes | 46 | $6,295 | $34 |
| Follow-up observation care per day, typically 35 minutes | 51 | $6,215 | $68 |
| Initial hospital observation care per day, typically 50 minutes | 46 | $5,965 | $113 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 28 | $4,497 | $112 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 27 | $3,008 | $111 |
| New patient visit (30+ min) | 22 | $1,842 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,826 | $87 |
2019: 18 services
| Return visit (30+ min) | 104 | $44,070 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $32,733 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 118 | $23,741 | $62 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 87 | $20,066 | $73 |
| Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | 67 | $17,296 | $43 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 127 | $15,752 | $116 |
| Short return visit | 82 | $5,924 | $22 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 57 | $5,548 | $37 |
| Psychiatric diagnostic evaluation with medical services | 43 | $5,401 | $113 |
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 13 | $4,268 | $115 |
| Short return visit (20+ min) | 29 | $4,168 | $64 |
| Return visit (30+ min) | 19 | $4,159 | $95 |
| Psychotherapy with evaluation and management visit, 30 minutes | 17 | $3,482 | $59 |
| Short return visit (20+ min) | 47 | $3,164 | $43 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 37 | $2,917 | $75 |
| Psychiatric diagnostic evaluation with medical services | 14 | $1,705 | $122 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,377 | $92 |
| New patient custodial care facility, group care, or assisted living visit, typically 20 minutes | 11 | $438 | $40 |
2018: 12 services
| Return visit (30+ min) | 143 | $73,006 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $44,019 | $83 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 56 | $24,047 | $72 |
| Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | 73 | $19,625 | $41 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 148 | $17,037 | $107 |
| Psychiatric diagnostic evaluation with medical services | 39 | $4,535 | $108 |
| Return visit (30+ min) | 17 | $3,904 | $87 |
| Hospital discharge day management, more than 30 minutes | 34 | $3,488 | $87 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $2,359 | $71 |
| Psychotherapy with evaluation and management visit, 30 minutes | 13 | $2,264 | $53 |
| Psychiatric diagnostic evaluation with medical services | 19 | $2,094 | $110 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 15 | $1,516 | $33 |
2017: 8 services
| Return visit (30+ min) | 109 | $52,983 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 159 | $47,194 | $81 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 154 | $18,999 | $105 |
| Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | 63 | $10,364 | $36 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 27 | $5,862 | $71 |
| Hospital discharge day management, more than 30 minutes | 43 | $4,283 | $84 |
| Psychiatric diagnostic evaluation with medical services | 29 | $3,331 | $111 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $873 | $67 |
2016: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 155 | $43,297 | $81 |
| Return visit (30+ min) | 40 | $23,361 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 143 | $17,041 | $106 |
| Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | 41 | $7,078 | $40 |
| Hospital discharge day management, more than 30 minutes | 38 | $4,023 | $87 |
| Psychiatric diagnostic evaluation with medical services | 20 | $2,266 | $108 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 27 | $1,764 | $26 |
2015: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 186 | $74,243 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 96 | $12,456 | $108 |
| Hospital discharge day management, more than 30 minutes | 69 | $7,010 | $89 |
| Psychiatric diagnostic evaluation | 55 | $6,423 | $102 |
| Psychiatric diagnostic evaluation with medical services | 54 | $6,346 | $113 |
| Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | 17 | $2,228 | $45 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 20 | $1,892 | $33 |
2014: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 205 | $78,100 | $85 |
| Psychiatric diagnostic evaluation | 114 | $12,505 | $103 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 92 | $11,159 | $106 |
| Hospital discharge day management, more than 30 minutes | 99 | $10,342 | $88 |
| Return visit (30+ min) | 26 | $9,024 | $84 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 34 | $5,308 | $33 |
| Psychiatric diagnostic evaluation | 13 | $1,390 | $107 |
2013: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 213 | $84,315 | $83 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 123 | $16,064 | $103 |
| Hospital discharge day management, more than 30 minutes | 130 | $14,270 | $86 |
| Psychiatric diagnostic evaluation with medical services | 106 | $10,343 | $94 |
| Return visit (30+ min) | 23 | $6,034 | $74 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 37 | $4,889 | $31 |
| Psychiatric diagnostic evaluation | 34 | $4,288 | $126 |
| Return visit (30+ min) | 11 | $3,194 | $49 |
| Psychiatric diagnostic evaluation | 24 | $2,318 | $93 |
| Psychiatric diagnostic evaluation with medical services | 21 | $2,132 | $102 |
| Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | 18 | $322 | $10 |
Medicaid work
$74,822 in 2024
Medicaid paid $74,822 for 4,075 billed services this clinician did in 2024, up to 51 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 356 | $36,990 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 292 | $17,796 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 806 | $10,226 |
| Psychiatric diagnostic evaluation with medical services | 35 | $6,273 |
| Short return visit (20+ min) | 191 | $2,099 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 29 | $1,095 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 71 | $343 |
| PSYCHOTHERAPY W/PATIENT 30 MINUTES | 18 | $0 |
| GROUP PSYCHOTHERAPY | 2,277 | $0 |
| 2024 | 4,075 | 9 | 51 | $74,822 |
| 2023 | 7,010 | 6 | 45 | $100,895 |
| 2022 | 4,293 | 7 | 43 | $66,511 |
| 2021 | 4,767 | 2 | 43 | $1,373 |
| 2020 | 3,671 | 3 | 37 | $1,897 |
| 2019 | 2,980 | 5 | 27 | $1,943 |
| 2018 | 2,268 | 5 | 20 | $2,915 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 362 | $89,816 |
| Short return visit (20+ min) | 347 | $5,284 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 272 | $4,140 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 25 | $1,097 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $559 |
| GROUP PSYCHOTHERAPY | 5,992 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 197 | $48,623 |
| SBSQ OBSERVATION CARE/DAY 25 MINUTES | 417 | $8,633 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 62 | $3,056 |
| Psychiatric diagnostic evaluation with medical services | 26 | $2,685 |
| Short return visit (20+ min) | 161 | $2,239 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 51 | $1,276 |
| GROUP PSYCHOTHERAPY | 3,379 | $0 |
2021
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 28 | $1,373 |
| GROUP PSYCHOTHERAPY | 4,739 | $0 |
2020
| SBSQ OBSERVATION CARE/DAY 25 MINUTES | 174 | $1,250 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 14 | $647 |
| GROUP PSYCHOTHERAPY | 3,483 | $0 |
2019
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 28 | $1,163 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 13 | $517 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 100 | $263 |
| GROUP PSYCHOTHERAPY | 2,814 | $0 |
| Short return visit | 25 | $0 |
2018
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 67 | $2,380 |
| Domiciliary or rest home visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self-limited or minor. Typically, 15 minutes are spent with the patient and/or family or caregiver. | 42 | $535 |
| GROUP PSYCHOTHERAPY | 2,119 | $0 |
| Return visit (30+ min) | 28 | $0 |
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 12 | $0 |
Drugs they prescribed that Part D paid
$231,189
Pharmacies billed $231,189 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,551 generic and 78 brand-name prescriptions · $231,189 in drug cost · 298 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Abilify Maintena | 12 | $29,767 | $2,481 |
| Caplyta | 16 | $26,794 | $1,675 |
| Olanzapine Odt | 58 | $11,841 | $204 |
| Clomipramine | 21 | $10,561 | $503 |
| Divalproex Sodium Er | 84 | $6,771 | $81 |
See all 46 drugs
| Abilify Maintena | 12 | $29,767 | $2,481 |
| Caplyta | 16 | $26,794 | $1,675 |
| Olanzapine Odt | 58 | $11,841 | $204 |
| Clomipramine | 21 | $10,561 | $503 |
| Divalproex Sodium Er | 84 | $6,771 | $81 |
| Aripiprazole | 70 | $6,584 | $94 |
| Risperdal | 12 | $3,460 | $288 |
| Quetiapine | 209 | $3,334 | $16 |
| Olanzapine | 165 | $3,177 | $19 |
| Clozapine | 43 | $3,164 | $74 |
| Haloperidol | 69 | $2,503 | $36 |
| Paliperidone Er | 13 | $2,287 | $176 |
| Divalproex | 55 | $1,661 | $30 |
| Benztropine Mesylate | 124 | $1,660 | $13 |
| Lurasidone | 25 | $1,361 | $54 |
| Trazodone | 154 | $1,307 | $8 |
| Risperidone | 108 | $1,124 | $10 |
| Bupropion Hcl Sr | 58 | $1,064 | $18 |
| Duloxetine | 49 | $1,048 | $21 |
| Bupropion Xl | 70 | $1,021 | $15 |
| Chlorpromazine | 11 | $938 | $85 |
| Gabapentin | 67 | $894 | $13 |
| Quetiapine Fumarate Er | 17 | $879 | $52 |
| Fluvoxamine Maleate | 18 | $735 | $41 |
| Carbamazepine | 14 | $697 | $50 |
| Fluoxetine | 84 | $582 | $7 |
| Buspirone | 66 | $565 | $9 |
| Alprazolam | 85 | $528 | $6 |
| Lorazepam | 96 | $506 | $5 |
| Escitalopram | 66 | $488 | $7 |
| Lithium Carbonate | 37 | $464 | $13 |
| Zolpidem | 59 | $381 | $6 |
| Sertraline | 60 | $351 | $6 |
| Lamotrigine | 46 | $313 | $7 |
| Clonazepam | 74 | $300 | $4 |
| Temazepam | 30 | $299 | $10 |
| Memantine | 23 | $273 | $12 |
| Prazosin | 30 | $272 | $9 |
| Hydroxyzine Pamoate | 29 | $268 | $9 |
| Amitriptyline | 16 | $217 | $14 |
| Topiramate | 19 | $188 | $10 |
| Mirtazapine | 17 | $156 | $9 |
| Citalopram Hbr | 41 | $141 | $3 |
| Paroxetine | 14 | $124 | $9 |
| Diazepam | 27 | $120 | $4 |
| Donepezil | 27 | $71 | $3 |
Year by year
| 2024 | 2,629 | 213 | None | 3% | $231,189 |
| 2023 | 3,365 | 202 | 0% (0) | None | $331,680 |
| 2022 | 3,395 | 216 | None | 4% | $300,591 |
| 2021 | 3,570 | 211 | None | 5% | $314,663 |
| 2020 | 3,454 | 168 | None | 5% | $327,444 |
| 2019 | 3,200 | 203 | 0% (0) | 6% | $362,451 |
| 2018 | 2,807 | 199 | None | 4% | $269,144 |
| 2017 | 2,585 | 190 | None | 6% | $206,064 |
| 2016 | 2,333 | 162 | None | 8% | $212,482 |
| 2015 | 3,151 | 218 | None | 14% | $466,089 |
| 2014 | 1,300 | 206 | None | 12% | $150,676 |
| 2013 | 1,266 | 182 | None | 16% | $115,725 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 48 drugs
| Olanzapine Odt | 107 | $35,769 | $334 |
| Clomipramine | 23 | $17,337 | $754 |
| Risperidone Odt | 55 | $14,939 | $272 |
| Latuda | 13 | $14,309 | $1,101 |
| Quetiapine Fumarate Er | 54 | $10,815 | $200 |
| Aripiprazole | 113 | $10,780 | $95 |
| Divalproex Sodium Er | 94 | $9,814 | $104 |
| Quetiapine | 269 | $9,542 | $35 |
| Olanzapine | 226 | $9,007 | $40 |
| Lurasidone | 20 | $5,240 | $262 |
| Paliperidone Er | 18 | $4,403 | $245 |
| Risperdal | 12 | $3,743 | $312 |
| Clozapine | 43 | $3,688 | $86 |
| Divalproex | 95 | $3,118 | $33 |
| Benztropine Mesylate | 196 | $2,813 | $14 |
| Risperidone | 143 | $2,443 | $17 |
| Trazodone | 173 | $2,294 | $13 |
| Haloperidol | 61 | $2,189 | $36 |
| Escitalopram | 113 | $1,840 | $16 |
| Buspirone | 98 | $1,553 | $16 |
| Temazepam | 68 | $1,533 | $23 |
| Sertraline | 109 | $1,434 | $13 |
| Duloxetine | 49 | $1,412 | $29 |
| Alprazolam | 117 | $1,274 | $11 |
| Gabapentin | 60 | $1,239 | $21 |
| Valproic Acid | 17 | $1,158 | $68 |
| Bupropion Xl | 43 | $1,120 | $26 |
| Lorazepam | 115 | $1,102 | $10 |
| Fluoxetine | 102 | $1,012 | $10 |
| Clonazepam | 90 | $923 | $10 |
| Memantine | 12 | $902 | $75 |
| Paroxetine | 49 | $662 | $14 |
| Carbamazepine | 11 | $629 | $57 |
| Bupropion Hcl Sr | 37 | $542 | $15 |
| Zolpidem | 50 | $532 | $11 |
| Fluvoxamine Maleate | 13 | $459 | $35 |
| Prazosin | 13 | $454 | $35 |
| Lithium Carbonate | 44 | $430 | $10 |
| Hydroxyzine Pamoate | 38 | $423 | $11 |
| Donepezil | 24 | $389 | $16 |
| Lamotrigine | 38 | $369 | $10 |
| Haloperidol Decanoate | 15 | $330 | $22 |
| Topiramate | 17 | $257 | $15 |
| Citalopram Hbr | 36 | $246 | $7 |
| Atorvastatin | 20 | $243 | $12 |
| Mirtazapine | 23 | $225 | $10 |
| Levothyroxine | 13 | $151 | $12 |
| Diazepam | 16 | $94 | $6 |
2022: 49 drugs
| Latuda | 26 | $40,156 | $1,544 |
| Invega Sustenna | 14 | $38,180 | $2,727 |
| Abilify Maintena | 11 | $29,874 | $2,716 |
| Olanzapine Odt | 118 | $27,280 | $231 |
| Aripiprazole | 124 | $25,475 | $205 |
| Divalproex Sodium Er | 104 | $14,142 | $136 |
| Clozapine | 60 | $11,308 | $188 |
| Clomipramine | 14 | $10,198 | $728 |
| Quetiapine | 290 | $9,849 | $34 |
| Risperidone Odt | 42 | $9,661 | $230 |
| Olanzapine | 201 | $5,608 | $28 |
| Quetiapine Fumarate Er | 52 | $5,498 | $106 |
| Vimpat | 16 | $5,129 | $321 |
| Risperdal | 12 | $3,687 | $307 |
| Divalproex | 98 | $3,356 | $34 |
| Haloperidol | 59 | $3,251 | $55 |
| Benztropine Mesylate | 210 | $2,536 | $12 |
| Risperidone | 155 | $2,530 | $16 |
| Ziprasidone | 16 | $1,718 | $107 |
| Trazodone | 207 | $1,588 | $8 |
| Buspirone | 76 | $1,572 | $21 |
| Duloxetine | 38 | $1,345 | $35 |
| Bupropion Xl | 40 | $1,300 | $33 |
| Escitalopram | 118 | $1,228 | $10 |
| Alprazolam | 89 | $1,123 | $13 |
| Lorazepam | 125 | $914 | $7 |
| Fluoxetine | 80 | $681 | $9 |
| Paroxetine | 67 | $674 | $10 |
| Valproic Acid | 14 | $656 | $47 |
| Sertraline | 72 | $636 | $9 |
| Gabapentin | 53 | $601 | $11 |
| Lamotrigine | 55 | $585 | $11 |
| Haloperidol Decanoate | 24 | $565 | $24 |
| Clonazepam | 101 | $534 | $5 |
| Levetiracetam | 16 | $462 | $29 |
| Amitriptyline | 23 | $457 | $20 |
| Haloperidol Decanoate 100 | 12 | $442 | $37 |
| Lithium Carbonate | 52 | $403 | $8 |
| Zolpidem | 82 | $401 | $5 |
| Topiramate | 41 | $400 | $10 |
| Hydroxyzine Pamoate | 53 | $393 | $7 |
| Temazepam | 37 | $388 | $10 |
| Bupropion Hcl Sr | 33 | $362 | $11 |
| Carbamazepine | 11 | $317 | $29 |
| Diazepam | 23 | $162 | $7 |
| Mirtazapine | 12 | $148 | $12 |
| Hydroxyzine | 14 | $107 | $8 |
| Citalopram Hbr | 36 | $89 | $2 |
| Donepezil | 14 | $56 | $4 |
2021: 48 drugs
| Latuda | 54 | $82,944 | $1,536 |
| Invega Sustenna | 20 | $53,590 | $2,679 |
| Olanzapine Odt | 91 | $22,170 | $244 |
| Aripiprazole | 119 | $13,133 | $110 |
| Divalproex Sodium Er | 135 | $12,938 | $96 |
| Clozapine | 101 | $11,584 | $115 |
| Quetiapine Fumarate Er | 38 | $11,087 | $292 |
| Clomipramine | 17 | $10,534 | $620 |
| Quetiapine | 243 | $6,672 | $27 |
| Divalproex | 152 | $5,466 | $36 |
| Olanzapine | 241 | $5,251 | $22 |
| Haloperidol | 77 | $4,333 | $56 |
| Vimpat | 12 | $3,600 | $300 |
| Risperidone Odt | 20 | $3,217 | $161 |
| Bupropion Xl | 72 | $2,185 | $30 |
| Risperidone | 155 | $2,158 | $14 |
| Benztropine Mesylate | 195 | $2,047 | $10 |
| Buspirone | 59 | $2,012 | $34 |
| Trazodone | 222 | $1,795 | $8 |
| Duloxetine | 57 | $1,398 | $25 |
| Buprenorphine-Naloxone | 11 | $1,229 | $112 |
| Escitalopram | 137 | $1,078 | $8 |
| Zolpidem | 137 | $865 | $6 |
| Alprazolam | 86 | $795 | $9 |
| Haloperidol Decanoate | 25 | $768 | $31 |
| Lorazepam | 117 | $764 | $7 |
| Gabapentin | 47 | $677 | $14 |
| Valproic Acid | 15 | $660 | $44 |
| Lithium Carbonate | 60 | $620 | $10 |
| Clonazepam | 93 | $550 | $6 |
| Fluoxetine | 69 | $500 | $7 |
| Mirtazapine | 42 | $495 | $12 |
| Levetiracetam | 17 | $451 | $27 |
| Haloperidol Decanoate 100 | 12 | $450 | $38 |
| Topiramate | 45 | $445 | $10 |
| Amitriptyline | 20 | $414 | $21 |
| Paroxetine | 41 | $411 | $10 |
| Temazepam | 43 | $403 | $9 |
| Lamotrigine | 41 | $400 | $10 |
| Sertraline | 45 | $358 | $8 |
| Bupropion Hcl Sr | 32 | $334 | $10 |
| Ziprasidone | 16 | $328 | $21 |
| Hydroxyzine Pamoate | 39 | $315 | $8 |
| Citalopram Hbr | 50 | $210 | $4 |
| Donepezil | 37 | $210 | $6 |
| Prazosin | 12 | $207 | $17 |
| Bupropion | 11 | $89 | $8 |
| Atorvastatin | 11 | $74 | $7 |
2020: 46 drugs
| Latuda | 70 | $110,533 | $1,579 |
| Olanzapine Odt | 109 | $35,150 | $322 |
| Risperdal Consta | 17 | $17,045 | $1,003 |
| Divalproex Sodium Er | 111 | $14,514 | $131 |
| Aripiprazole | 113 | $13,586 | $120 |
| Fluphenazine | 21 | $13,071 | $622 |
| Quetiapine Fumarate Er | 26 | $12,517 | $481 |
| Quetiapine | 251 | $8,603 | $34 |
| Clozapine | 93 | $6,529 | $70 |
| Olanzapine | 264 | $6,212 | $24 |
| Haloperidol | 60 | $3,583 | $60 |
| Divalproex | 137 | $3,289 | $24 |
| Bupropion Xl | 65 | $2,387 | $37 |
| Benztropine Mesylate | 201 | $2,257 | $11 |
| Trazodone | 246 | $2,173 | $9 |
| Risperidone | 128 | $1,829 | $14 |
| Buspirone | 93 | $1,501 | $16 |
| Duloxetine | 66 | $1,006 | $15 |
| Hydroxyzine | 17 | $1,004 | $59 |
| Escitalopram | 128 | $969 | $8 |
| Oxcarbazepine | 12 | $894 | $74 |
| Gabapentin | 55 | $843 | $15 |
| Lorazepam | 103 | $830 | $8 |
| Loxapine | 11 | $747 | $68 |
| Lithium Carbonate | 65 | $733 | $11 |
| Clonazepam | 103 | $660 | $6 |
| Bupropion Hcl Sr | 31 | $656 | $21 |
| Zolpidem | 113 | $619 | $5 |
| Alprazolam | 57 | $403 | $7 |
| Topiramate | 38 | $399 | $11 |
| Guanfacine | 11 | $338 | $31 |
| Paroxetine | 40 | $336 | $8 |
| Bupropion | 26 | $332 | $13 |
| Temazepam | 35 | $327 | $9 |
| Fluoxetine | 65 | $313 | $5 |
| Venlafaxine | 12 | $311 | $26 |
| Mirtazapine | 29 | $283 | $10 |
| Sertraline | 45 | $278 | $6 |
| Prazosin | 17 | $277 | $16 |
| Lamotrigine | 40 | $257 | $6 |
| Citalopram Hbr | 48 | $215 | $4 |
| Amitriptyline | 24 | $196 | $8 |
| Donepezil | 19 | $166 | $9 |
| Hydroxyzine Pamoate | 20 | $112 | $6 |
| Pantoprazole | 13 | $85 | $7 |
| Ropinirole | 11 | $44 | $4 |
2019: 51 drugs
| Latuda | 62 | $91,773 | $1,480 |
| Invega Sustenna | 17 | $45,896 | $2,700 |
| Olanzapine Odt | 119 | $26,797 | $225 |
| Aripiprazole | 115 | $23,930 | $208 |
| Vraylar | 12 | $15,166 | $1,264 |
| Saphris | 12 | $14,901 | $1,242 |
| Divalproex Sodium Er | 103 | $14,664 | $142 |
| Fluphenazine | 30 | $13,457 | $449 |
| Paliperidone Er | 17 | $11,231 | $661 |
| Risperdal Consta | 11 | $11,204 | $1,019 |
| Clomipramine | 12 | $10,656 | $888 |
| Quetiapine | 284 | $8,362 | $29 |
| Quetiapine Fumarate Er | 25 | $7,219 | $289 |
| Clozapine | 40 | $4,579 | $114 |
| Olanzapine | 241 | $4,389 | $18 |
| Haloperidol | 60 | $3,896 | $65 |
| Divalproex | 129 | $2,555 | $20 |
| Benztropine Mesylate | 188 | $2,263 | $12 |
| Trazodone | 192 | $2,241 | $12 |
| Bupropion Xl | 33 | $1,427 | $43 |
| Risperidone | 97 | $1,298 | $13 |
| Buspirone | 87 | $1,217 | $14 |
| Gabapentin | 44 | $1,157 | $26 |
| Zolpidem | 119 | $926 | $8 |
| Oxcarbazepine | 13 | $901 | $69 |
| Duloxetine | 27 | $880 | $33 |
| Loxapine | 12 | $849 | $71 |
| Lorazepam | 111 | $833 | $8 |
| Clonazepam | 87 | $805 | $9 |
| Escitalopram | 76 | $770 | $10 |
| Paroxetine | 66 | $714 | $11 |
| Hydroxyzine | 19 | $656 | $35 |
| Valproic Acid | 13 | $611 | $47 |
| Lithium Carbonate | 48 | $610 | $13 |
| Temazepam | 40 | $587 | $15 |
| Bupropion Hcl Sr | 35 | $555 | $16 |
| Sertraline | 73 | $534 | $7 |
| Lamotrigine | 47 | $449 | $10 |
| Prazosin | 14 | $411 | $29 |
| Donepezil | 35 | $366 | $10 |
| Omeprazole | 17 | $352 | $21 |
| Mirtazapine | 32 | $296 | $9 |
| Fluoxetine | 58 | $295 | $5 |
| Amitriptyline | 21 | $289 | $14 |
| Topiramate | 31 | $264 | $9 |
| Hydroxyzine Pamoate | 28 | $253 | $9 |
| Venlafaxine | 13 | $243 | $19 |
| Bupropion | 17 | $218 | $13 |
| Citalopram Hbr | 35 | $217 | $6 |
| Alprazolam | 30 | $173 | $6 |
| Diazepam | 12 | $74 | $6 |
2018: 47 drugs
| Latuda | 43 | $64,213 | $1,493 |
| Invega Sustenna | 12 | $30,507 | $2,542 |
| Olanzapine Odt | 123 | $25,420 | $207 |
| Aripiprazole | 84 | $24,298 | $289 |
| Saphris | 13 | $16,142 | $1,242 |
| Divalproex Sodium Er | 86 | $15,657 | $182 |
| Clomipramine | 12 | $12,379 | $1,032 |
| Paliperidone Er | 14 | $9,051 | $646 |
| Quetiapine | 270 | $6,060 | $22 |
| Haloperidol | 71 | $4,230 | $60 |
| Divalproex | 152 | $3,021 | $20 |
| Fluphenazine | 31 | $2,961 | $96 |
| Olanzapine | 166 | $2,726 | $16 |
| Benztropine Mesylate | 179 | $2,299 | $13 |
| Trazodone | 152 | $1,834 | $12 |
| Risperidone | 113 | $1,435 | $13 |
| Gabapentin | 63 | $1,314 | $21 |
| Lorazepam | 135 | $1,030 | $8 |
| Oxcarbazepine | 18 | $1,000 | $56 |
| Loxapine | 14 | $932 | $67 |
| Bupropion Xl | 19 | $907 | $48 |
| Clonazepam | 86 | $855 | $10 |
| Ziprasidone | 14 | $829 | $59 |
| Zolpidem | 98 | $807 | $8 |
| Valproic Acid | 12 | $805 | $67 |
| Hydroxyzine | 14 | $785 | $56 |
| Lithium Carbonate | 63 | $776 | $12 |
| Buspirone | 50 | $709 | $14 |
| Temazepam | 58 | $637 | $11 |
| Escitalopram | 52 | $596 | $11 |
| Sertraline | 62 | $571 | $9 |
| Paroxetine | 37 | $447 | $12 |
| Lamotrigine | 43 | $346 | $8 |
| Duloxetine | 13 | $343 | $26 |
| Bupropion | 18 | $336 | $19 |
| Perphenazine | 11 | $310 | $28 |
| Mirtazapine | 33 | $306 | $9 |
| Hydroxyzine Pamoate | 28 | $289 | $10 |
| Fluoxetine | 38 | $262 | $7 |
| Citalopram Hbr | 37 | $252 | $7 |
| Donepezil | 27 | $233 | $9 |
| Topiramate | 19 | $212 | $11 |
| Amitriptyline | 12 | $209 | $17 |
| Venlafaxine | 12 | $179 | $15 |
| Trihexyphenidyl | 16 | $168 | $11 |
| Alprazolam | 12 | $90 | $8 |
| Bupropion Hcl Sr | 13 | $89 | $7 |
2017: 44 drugs
| Aripiprazole | 76 | $36,195 | $476 |
| Latuda | 20 | $25,545 | $1,277 |
| Olanzapine Odt | 115 | $20,950 | $182 |
| Saphris | 17 | $19,548 | $1,150 |
| Clomipramine | 20 | $16,494 | $825 |
| Divalproex Sodium Er | 72 | $14,125 | $196 |
| Paliperidone Er | 12 | $8,161 | $680 |
| Quetiapine | 269 | $6,242 | $23 |
| Quetiapine Fumarate Er | 11 | $3,919 | $356 |
| Haloperidol | 53 | $3,140 | $59 |
| Chlorpromazine | 13 | $2,723 | $209 |
| Divalproex | 131 | $2,666 | $20 |
| Benztropine Mesylate | 163 | $2,449 | $15 |
| Fluphenazine | 21 | $2,322 | $111 |
| Risperidone | 160 | $2,264 | $14 |
| Trazodone | 141 | $2,007 | $14 |
| Olanzapine | 102 | $1,992 | $20 |
| Ziprasidone | 18 | $1,230 | $68 |
| Thiothixene | 12 | $1,206 | $101 |
| Temazepam | 70 | $987 | $14 |
| Sertraline | 74 | $924 | $12 |
| Memantine | 11 | $910 | $83 |
| Lithium Carbonate | 78 | $893 | $11 |
| Bupropion | 34 | $893 | $26 |
| Zolpidem | 101 | $889 | $9 |
| Bupropion Xl | 18 | $821 | $46 |
| Valproic Acid | 12 | $722 | $60 |
| Clonazepam | 80 | $674 | $8 |
| Amantadine | 12 | $573 | $48 |
| Gabapentin | 32 | $567 | $18 |
| Buspirone | 31 | $553 | $18 |
| Lorazepam | 69 | $516 | $7 |
| Paroxetine | 49 | $514 | $10 |
| Escitalopram | 42 | $513 | $12 |
| Amitriptyline | 16 | $380 | $24 |
| Trihexyphenidyl | 33 | $367 | $11 |
| Mirtazapine | 36 | $315 | $9 |
| Duloxetine | 15 | $302 | $20 |
| Citalopram Hbr | 33 | $291 | $9 |
| Lamotrigine | 35 | $264 | $8 |
| Fluoxetine | 45 | $229 | $5 |
| Hydroxyzine Pamoate | 21 | $224 | $11 |
| Donepezil | 15 | $169 | $11 |
| Diazepam | 24 | $123 | $5 |
2016: 44 drugs
| Aripiprazole | 74 | $40,783 | $551 |
| Latuda | 27 | $33,115 | $1,226 |
| Seroquel Xr | 16 | $17,596 | $1,100 |
| Clomipramine | 21 | $15,256 | $726 |
| Olanzapine Odt | 87 | $11,112 | $128 |
| Divalproex Sodium Er | 51 | $8,806 | $173 |
| Paliperidone Er | 12 | $8,373 | $698 |
| Quetiapine | 335 | $8,023 | $24 |
| Divalproex | 134 | $3,642 | $27 |
| Clozapine | 23 | $3,625 | $158 |
| Fluphenazine | 25 | $2,374 | $95 |
| Risperidone | 151 | $2,129 | $14 |
| Benztropine Mesylate | 155 | $2,051 | $13 |
| Haloperidol | 45 | $2,017 | $45 |
| Chlorpromazine | 12 | $1,877 | $156 |
| Trazodone | 160 | $1,506 | $9 |
| Olanzapine | 66 | $1,309 | $20 |
| Thiothixene | 12 | $1,268 | $106 |
| Ziprasidone | 14 | $1,108 | $79 |
| Duloxetine | 22 | $905 | $41 |
| Bupropion Xl | 29 | $803 | $28 |
| Valproic Acid | 15 | $768 | $51 |
| Memantine | 14 | $742 | $53 |
| Lithium Carbonate | 66 | $740 | $11 |
| Paroxetine | 49 | $593 | $12 |
| Amantadine | 12 | $583 | $49 |
| Escitalopram | 51 | $574 | $11 |
| Sertraline | 56 | $540 | $10 |
| Zolpidem | 70 | $514 | $7 |
| Temazepam | 35 | $409 | $12 |
| Lorazepam | 64 | $409 | $6 |
| Bupropion | 12 | $342 | $29 |
| Clonazepam | 49 | $335 | $7 |
| Amitriptyline | 12 | $306 | $25 |
| Lamotrigine | 27 | $304 | $11 |
| Mirtazapine | 36 | $294 | $8 |
| Buspirone | 24 | $226 | $9 |
| Gabapentin | 17 | $220 | $13 |
| Hydroxyzine Pamoate | 18 | $209 | $12 |
| Citalopram Hbr | 30 | $205 | $7 |
| Donepezil | 16 | $195 | $12 |
| Fluoxetine | 36 | $177 | $5 |
| Trihexyphenidyl | 14 | $126 | $9 |
| Diazepam | 17 | $117 | $7 |
2015: 45 drugs
| Abilify | 105 | $117,794 | $1,122 |
| Invega | 57 | $69,125 | $1,213 |
| Latuda | 62 | $63,184 | $1,019 |
| Seroquel Xr | 41 | $53,231 | $1,298 |
| Fanapt | 33 | $30,289 | $918 |
| Olanzapine Odt | 98 | $22,418 | $229 |
| Divalproex Sodium Er | 82 | $14,984 | $183 |
| Aripiprazole | 16 | $13,294 | $831 |
| Clomipramine | 12 | $13,231 | $1,103 |
| Quetiapine | 343 | $9,299 | $27 |
| Divalproex | 180 | $5,186 | $29 |
| Nuedexta | 11 | $3,947 | $359 |
| Clozapine | 44 | $3,754 | $85 |
| Haloperidol | 65 | $3,664 | $56 |
| Risperidone | 222 | $3,266 | $15 |
| Chlorpromazine | 19 | $2,749 | $145 |
| Duloxetine | 23 | $2,579 | $112 |
| Olanzapine | 125 | $2,327 | $19 |
| Benztropine Mesylate | 201 | $2,278 | $11 |
| Zolpidem | 166 | $1,661 | $10 |
| Ziprasidone | 13 | $1,618 | $124 |
| Trazodone | 175 | $1,316 | $8 |
| Valproic Acid | 24 | $1,280 | $53 |
| Thiothixene | 14 | $1,263 | $90 |
| Buspirone | 45 | $847 | $19 |
| Lithium Carbonate | 77 | $673 | $9 |
| Lorazepam | 99 | $673 | $7 |
| Escitalopram | 65 | $602 | $9 |
| Fluoxetine | 63 | $580 | $9 |
| Fluphenazine | 13 | $545 | $42 |
| Bupropion Hcl Sr | 30 | $536 | $18 |
| Bupropion Xl | 15 | $487 | $32 |
| Paroxetine | 46 | $477 | $10 |
| Mirtazapine | 47 | $468 | $10 |
| Citalopram Hbr | 66 | $427 | $6 |
| Clonazepam | 58 | $318 | $5 |
| Gabapentin | 22 | $310 | $14 |
| Donepezil | 31 | $306 | $10 |
| Sertraline | 38 | $285 | $8 |
| Amitriptyline | 12 | $239 | $20 |
| Temazepam | 19 | $208 | $11 |
| Lamotrigine | 25 | $198 | $8 |
| Trihexyphenidyl | 25 | $164 | $7 |
| Alprazolam | 22 | $157 | $7 |
| Hydroxyzine Pamoate | 17 | $128 | $8 |
2014: 26 drugs
| Abilify | 33 | $29,763 | $902 |
| Latuda | 29 | $20,391 | $703 |
| Quetiapine | 164 | $20,264 | $124 |
| Seroquel Xr | 19 | $15,340 | $807 |
| Divalproex Sodium Er | 34 | $9,547 | $281 |
| Olanzapine | 72 | $9,111 | $127 |
| Olanzapine Odt | 22 | $5,911 | $269 |
| Nuedexta | 11 | $3,612 | $328 |
| Risperidone | 79 | $1,082 | $14 |
| Divalproex | 56 | $1,062 | $19 |
| Zolpidem | 83 | $801 | $10 |
| Haloperidol | 20 | $744 | $37 |
| Benztropine Mesylate | 58 | $552 | $10 |
| Paroxetine | 41 | $450 | $11 |
| Trazodone | 60 | $405 | $7 |
| Lorazepam | 51 | $371 | $7 |
| Mirtazapine | 36 | $348 | $10 |
| Escitalopram | 28 | $330 | $12 |
| Lithium Carbonate | 31 | $303 | $10 |
| Donepezil | 20 | $226 | $11 |
| Sertraline | 26 | $223 | $9 |
| Citalopram Hbr | 29 | $177 | $6 |
| Alprazolam | 26 | $165 | $6 |
| Clonazepam | 25 | $129 | $5 |
| Temazepam | 11 | $78 | $7 |
| Fluoxetine | 11 | $76 | $7 |
2013: 28 drugs
| Abilify | 46 | $33,194 | $722 |
| Olanzapine | 73 | $16,503 | $226 |
| Seroquel Xr | 20 | $14,481 | $724 |
| Quetiapine | 106 | $13,646 | $129 |
| Divalproex Sodium Er | 30 | $4,359 | $145 |
| Ziprasidone | 21 | $4,355 | $207 |
| Cymbalta | 16 | $3,608 | $226 |
| Divalproex | 75 | $1,649 | $22 |
| Risperidone | 80 | $1,598 | $20 |
| Benztropine Mesylate | 84 | $757 | $9 |
| Bupropion Hcl Sr | 20 | $720 | $36 |
| Escitalopram | 17 | $657 | $39 |
| Lorazepam | 63 | $597 | $9 |
| Paroxetine | 40 | $577 | $14 |
| Haloperidol | 19 | $568 | $30 |
| Donepezil | 32 | $504 | $16 |
| Lithium Carbonate | 37 | $480 | $13 |
| Sertraline | 45 | $438 | $10 |
| Gabapentin | 16 | $400 | $25 |
| Trazodone | 47 | $364 | $8 |
| Zolpidem | 48 | $362 | $8 |
| Bupropion | 17 | $330 | $19 |
| Mirtazapine | 25 | $218 | $9 |
| Fluoxetine | 16 | $169 | $11 |
| Clonazepam | 20 | $158 | $8 |
| Citalopram Hbr | 17 | $149 | $9 |
| Alprazolam | 16 | $114 | $7 |
| Simvastatin | 11 | $82 | $7 |
Money from drug and device companies
$1,402 in 2025
| 2025 | 10 | 54 | None | $1,402 |
| 2024 | 12 | 55 | None | $1,412 |
| 2023 | 12 | 60 | None | $1,431 |
| 2022 | 10 | 39 | None | $790 |
| 2021 | 11 | 33 | None | $658 |
| 2020 | 3 | 4 | None | $68 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Axsome Therapeutics | Auvelity | $268 | 8 payments
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $262 | 11 payments
|
| Abbvie | Vraylar | $216 | 10 payments
|
| Alkermes | Aristada | $148 | 5 payments
|
| Vanda Pharmaceuticals | Hetlioz | $146 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $128 | 5 payments
|
See all 54 published payments
| Axsome Therapeutics | Meals · 2025-12-18 | Auvelity | $22 |
| Vanda Pharmaceuticals | Meals · 2025-11-19 | Hetlioz | $23 |
| Abbvie | Meals · 2025-11-10 | Vraylar | $7 |
| Otsuka America Pharmaceutical | Meals · 2025-11-06 | Rexulti | $20 |
| Otsuka America Pharmaceutical | Meals · 2025-11-04 | Abilify Asimtufii | $25 |
| Axsome Therapeutics | Meals · 2025-10-23 | Auvelity | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-21 | Cobenfy | $31 |
| Abbvie | Meals · 2025-10-15 | Vraylar | $28 |
| Janssen Pharmaceuticals | Meals · 2025-10-09 | Invega Sustenna | $24 |
| Otsuka America Pharmaceutical | Meals · 2025-10-09 | Rexulti | $27 |
| Otsuka America Pharmaceutical | Meals · 2025-09-24 | Abilify Asimtufii | $21 |
| Abbvie | Meals · 2025-09-22 | Vraylar | $22 |
| Abbvie | Meals · 2025-09-19 | Vraylar | $26 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-11 | Cobenfy | $23 |
| Otsuka America Pharmaceutical | Meals · 2025-09-10 | Rexulti | $25 |
| Otsuka America Pharmaceutical | Meals · 2025-08-21 | Abilify Asimtufii | $30 |
| Abbvie | Meals · 2025-08-18 | Vraylar | $7 |
| Alkermes | Meals · 2025-08-13 | Aristada | $30 |
| Otsuka America Pharmaceutical | Meals · 2025-07-24 | Abilify Asimtufii | $27 |
| Axsome Therapeutics | Meals · 2025-07-22 | Auvelity | $22 |
| Janssen Pharmaceuticals | Meals · 2025-07-15 | Invega Sustenna | $27 |
| Alkermes | Meals · 2025-07-10 | Aristada | $23 |
| Otsuka America Pharmaceutical | Meals · 2025-06-27 | Abilify Asimtufii | $23 |
| Almatica Pharma | Meals · 2025-06-25 | Loreev Xr | $26 |
| Otsuka America Pharmaceutical | Meals · 2025-06-04 | Rexulti | $21 |
| Otsuka America Pharmaceutical | Meals · 2025-05-29 | Abilify Asimtufii | $17 |
| Abbvie | Meals · 2025-05-28 | Vraylar | $28 |
| Almatica Pharma | Meals · 2025-05-22 | Loreev Xr | $23 |
| Axsome Therapeutics | Meals · 2025-05-22 | Auvelity | $16 |
| Teva Pharmaceuticals USA | Meals · 2025-05-15 | Uzedy | $26 |
| Vanda Pharmaceuticals | Meals · 2025-05-14 | Hetlioz | $24 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-30 | Caplyta | $26 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-29 | Cobenfy | $28 |
| Alkermes | Meals · 2025-04-24 | Aristada | $31 |
| Abbvie | Meals · 2025-04-16 | Vraylar | $27 |
| Otsuka America Pharmaceutical | Meals · 2025-04-15 | Abilify Asimtufii | $27 |
| Almatica Pharma | Meals · 2025-04-09 | Loreev Xr | $27 |
| Vanda Pharmaceuticals | Meals · 2025-04-08 | Hetlioz | $39 |
| Abbvie | Meals · 2025-03-26 | Vraylar | $27 |
| Axsome Therapeutics | Meals · 2025-03-26 | Auvelity | $21 |
| Alkermes | Meals · 2025-03-20 | Aristada | $30 |
| Alkermes | Meals · 2025-03-18 | Aristada | $34 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-11 | Cobenfy | $19 |
| Almatica Pharma | Meals · 2025-03-06 | Loreev Xr | $20 |
| Vanda Pharmaceuticals | Meals · 2025-03-05 | Hetlioz | $29 |
| Axsome Therapeutics | Meals · 2025-02-27 | Auvelity | $20 |
| Abbvie | Meals · 2025-02-26 | Vraylar | $24 |
| Janssen Pharmaceuticals | Meals · 2025-02-04 | Invega Sustenna | $17 |
| Axsome Therapeutics | Meals · 2025-01-29 | Auvelity | $16 |
| Axsome Therapeutics | Meals · 2025-01-28 | Auvelity | $122 |
| Abbvie | Meals · 2025-01-23 | Vraylar | $20 |
| Vanda Pharmaceuticals | Meals · 2025-01-23 | Hetlioz | $32 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-15 | Cobenfy | $27 |
| Almatica Pharma | Meals · 2025-01-08 | Loreev Xr | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $1,412
| Vanda Pharmaceuticals | Hetlioz | $229 | 7 payments
|
| Axsome Therapeutics | Auvelity | $225 | 5 payments
|
| Otsuka America Pharmaceutical | Rexulti | $181 | 8 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $181 | 8 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $173 | 9 payments
|
| Abbvie | Vraylar | $164 | 7 payments
|
| Alkermes | Aristada | $140 | 6 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $27 | 1 payment
|
| Lundbeck | Abilify Asimtufii | $27 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $24 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $23 | 1 payment
|
| Almatica Pharma | Loreev Xr | $21 | 1 payment
|
2023: $1,431
| AbbVie | Vraylar | $386 | 15 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $227 | 11 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $223 | 6 payments
|
| Iti | Caplyta | $150 | 7 payments
|
| Alkermes | Aristada | $84 | 4 payments
|
| Lundbeck | Abilify Maintena | $78 | 4 payments
|
| Neurocrine Biosciences | Ingrezza | $71 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $59 | 3 payments
|
| Neuronetics | Neurostar Tms Therapy System | $58 | 3 payments
|
| BioXcel Therapeutics | Igalmi | $48 | 2 payments
|
| Indivior | Sublocade | $26 | 1 payment
|
| Vanda Pharmaceuticals | Hetlioz | $21 | 1 payment
|
2022: $790
| Iti | Caplyta | $188 | 11 payments
|
| Alkermes | Lybalvi | $177 | 8 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $124 | 5 payments
|
| Sunovion Pharmaceuticals | Latuda | $93 | 4 payments
|
| Abbvie | Vraylar | $53 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $45 | 2 payments
|
| Vanda Pharmaceuticals | Hetlioz | $44 | 2 payments
|
| Lundbeck | Abilify Maintena | $35 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $20 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $12 | 1 payment
|
2021: $658
| Alkermes | Aristada | $161 | 9 payments
|
| Sunovion Pharmaceuticals | Latuda | $123 | 5 payments
|
| Vanda Pharmaceuticals | Hetlioz | $110 | 6 payments
|
| Iti | Caplyta | $92 | 3 payments
|
| Lundbeck | Rexulti | $55 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $27 | 2 payments
|
| AbbVie | Vraylar | $26 | 1 payment
|
| Indivior | Perseris | $19 | 1 payment
|
| Boston Scientific | General Pain Management | $18 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $16 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $12 | 1 payment
|
2020: $68
| Allergan | Vraylar | $28 | 2 payments
|
| Eisai | Dayvigo | $22 | 1 payment
|
| Lundbeck | Rexulti | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 79.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1457546913
- Licence
- CA A111070California A111070: Current · expires 2028-02-29
- Group
- Kalpesh Bhavsar MD Professional Corporation · New U Therapy Center and Family Services Inc · Pacific Heritage Medical Group Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- Po Box 2008, Covina, CA, 91722
- NPI first listed
- 2007-09-07
- NPI last updated
- 2013-02-06
This is when the NPI record was last certified, not a medical board exam.